Zobrazeno 1 - 10
of 1 125
pro vyhledávání: '"A. Akenroye"'
Autor:
Sören Scholvin
Publikováno v:
Africa Spectrum, Vol 58 (2023)
Externí odkaz:
https://doaj.org/article/b0aef13cd35c4256ac02a940acca48ab
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Akenroye, Temidayo O., Oyedijo, Adegboyega, Abubakre, Alim, Zsidisin, George, El Baz, Jamal, Vishnu, C. R.
Publikováno v:
International Journal of Public Sector Management, 2024, Vol. 37, Issue 7, pp. 935-965.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJPSM-06-2024-0184
Autor:
Scholvin, Sören
Publikováno v:
Africa Spectrum; Apr2023, Vol. 58 Issue 1, p106-107, 2p
Autor:
Sören Scholvin
Publikováno v:
Africa Spectrum. 58:106-107
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract To date, most studies to identify biomarkers associated with response to the anti-interleukin 5 agent, mepolizumab, and to the anti-immunoglobulin E agent, omalizumab have focused on clinically available biomarkers, such as the peripheral bl
Externí odkaz:
https://doaj.org/article/e2c2018e2d224defb9c37b28df8d55bd
Autor:
Tanawin Nopsopon, Yulu Chen, Qingwen Chen, Craig E. Wheelock, Scott. T. Weiss, Michael McGeachie, Jessica Lasky-Su, Ayobami Akenroye
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Background There is limited evidence on biomarkers associated with response to the monoclonal antibodies currently approved for asthma treatment. We sought to identify circulatory metabolites associated with response to treatment with mepolizumab or
Externí odkaz:
https://doaj.org/article/586f865828d94072974804fb30f02c49
Autor:
Nopsopon, Tanawin, Brown, Alyson, Hahn, Georg, Rank, Matthew, Huybrechts, Krista F., Akenroye, Ayobami
Publikováno v:
In Respiratory Medicine November-December 2024 234
Autor:
Akenroye, Temidayo O., Oyedijo, Adegboyega, Rajan, Vishnu C., Zsidisin, George A., Mkansi, Marcia, Baz, Jamal El
Publikováno v:
Supply Chain Management: An International Journal, 2023, Vol. 28, Issue 7, pp. 43-61.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/SCM-12-2022-0457
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Introduction Biomarkers are needed to inform the choice of biologic therapy in patients with asthma given the increasing number of biologics. We aimed to identify proteins associated with response to omalizumab and mepolizumab. Methods Aptam
Externí odkaz:
https://doaj.org/article/9858690689914b519288b5425d047bb1